Viewing Study NCT06517758

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-02-03 @ 11:46 PM
Study NCT ID: NCT06517758
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2024-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Generalized Myasthenia Gravis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myasthenia Gravis View
None gMG View
None randomized View
None placebo-controlled View
None double-blind View
None phase III View
None AChR+ View
None SOC treatment View
None iptacopan View
None LNP023 View